C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1992
11/10/1992	US5162305 Polypeptide derivatives
11/10/1992	US5162227 Recombinant DNA vectors capable of expressing apoaequorin in E. coli
11/10/1992	US5162226 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
11/10/1992	US5162219 Reacting with amide bond forming agent in presence of polyamine; labels in immunoassay
11/10/1992	US5162217 Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof
11/10/1992	US5162216 Hybrid gene regulatory region operable in E. coli
11/10/1992	US5162215 Introducing nucleic acid sequence into pluripotent stem cells of embryos
11/10/1992	US5162208 Saccharomyces cerevisiae strain productive of a heterologous protein and process for preparing the said heterologous protein by fermentation of the said strain
11/10/1992	US5162207 Sucrose inducible expression vectors for bacillus sp.
11/10/1992	US5162206 Including a promoter consisting of bacteriophages and a marker; production of insulin, growth hormones, enzymes
11/10/1992	US5162114 Bone collagen matrix for xenogenic implants
11/10/1992	US5162112 Influenza vaccine
11/10/1992	US5162111 Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
11/10/1992	CA2086437A1 Phospholipid-targeted thrombolytic agents
11/09/1992	WO1992019745A1 Rfkbp: a novel prolyl isomerase and rapamycin/fk506 binding protein
11/09/1992	CA2102117A1 Rfkbp: a novel prolyl isomerase and rapamycin/fk506 binding protein
11/07/1992	WO1992019761A1 Assays for inhibitors of leukocyte adhesion
11/07/1992	WO1992019255A1 Gene manipulation and expression using genomic elements
11/07/1992	CA2109212A1 Assays for inhibitors of leukocyte adhesion
11/07/1992	CA2102628A1 Gene manipulation and expression using genomic elements
11/07/1992	CA2067973A1 Yeast-derived mitogen
11/05/1992	DE4214328A1 New phosphinate-contg. peptide derivs. - as collagenase inhibitors e.g. for treating gangrene or dental infections
11/04/1992	WO1992019752A1 Rna delivery vector
11/04/1992	WO1992019259A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
11/04/1992	EP0511940A2 Phosphono/biaryl substituted dipeptide derivatives
11/04/1992	EP0511866A2 Process for the crystallization of cyclic lipopeptides
11/04/1992	EP0511855A1 HBsAg escape mutant vaccine
11/04/1992	EP0511854A1 Multiple hepatitis B virus surface proteins which form particles
11/04/1992	EP0511830A2 Affinity purified heparin
11/04/1992	EP0511816A2 Neurotrophic peptide derivative
11/04/1992	EP0511747A1 Hybrid polypeptide containing an avidin binding polypeptide
11/04/1992	EP0511600A2 Long chain carboxylic acid imide ester
11/04/1992	EP0511559A1 Oligonucleotide probe reagent
11/04/1992	EP0511516A2 Schizosaccharomyces specific polypeptide
11/04/1992	EP0511393A1 Hirudine mutant, production thereof, anticoagulant, secretory vector, microorganism transformed by said vector, and production of product from said microorganism
11/04/1992	EP0511347A1 Meta-substituted phenyl alanine derivatives
11/04/1992	EP0511317A1 Composition to improve survival of biological materials
11/04/1992	EP0511306A1 Tumor killing effects of enterotoxins and related compounds
11/04/1992	EP0511302A1 Cytotoxic cell-specific protease-related molecules and methods
11/04/1992	EP0511285A1 Vector with multiple target response elements affecting gene expression
11/04/1992	EP0511263A1 A platelet cell adhesion molecule and variants thereof
11/04/1992	EP0511221A1 Process for enriching or cleaning hirudin.
11/04/1992	EP0317568B1 Use of granulocyte macrophage colony stimulating factor to prepare a medicament for treating bacterial infections
11/04/1992	EP0229782B1 Methods for identifying alleles associated with increased risk of diabetes
11/04/1992	EP0138854B1 Antigenically active amino acid sequences
11/04/1992	CN1065867A Peptides and mixtures thereof for detecting antibodies to hepatitis c virus
11/04/1992	CA2108886A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
11/04/1992	CA2086510A1 Rna delivry vector
11/03/1992	WO1992019265A1 Recombinant dna-derived cholera toxin subunit analogs
11/03/1992	US5160483 Fragment of TNF-α for promoting wound healing
11/03/1992	CA2102105A1 Recombinant dna-derived cholera toxin subunit analogs
11/03/1992	CA2067598A1 Recombinant adn molecules coding for a receptor chain for the t-cell antigen, preparation process, antibody and drugs containing them
11/03/1992	CA1309804C Purification by affinity binding to liposomes
11/03/1992	CA1309679C Serum free media for the growth of insect cells and expression of products thereby
11/03/1992	CA1309676C Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor viii:c
11/03/1992	CA1309674C Signal peptide for the excretion of peptides in streptomycetes
11/03/1992	CA1309671C Monoclonal antibodies to cyclosporins
11/03/1992	CA1309670C Monoclonal antibodies to mucin-like human differentiation antigens
11/02/1992	CA2067592A1 Phosphono/biaryl substituted dipeptide derviatives
11/02/1992	CA2067294A1 Process for crystalline cyclic lipopeptides
10/1992
10/31/1992	CA2067426A1 Membrane bound probes
10/30/1992	CA2067590A1 Multiple hepatitis b virus surface proteins which form particles
10/30/1992	CA2067405A1 Schizosaccharomyces-specific polypeptides
10/30/1992	CA2067290A1 Hepatitis b virus surface proteins with reduced host carbohydrate content
10/30/1992	CA2067003A1 Hbsag escape mutant vaccine
10/29/1992	WO1992018868A1 Crosstalk inhibitors and their uses
10/29/1992	WO1992018634A1 Plant promoter involved in controlling lipid biosynthesis in seeds
10/29/1992	WO1992018633A1 Lantibiotics similar to nisin a, lactic acid bacteria which produce such lantibiotics, method for constructing such lactic acid bacteria and method for preserving foodstuffs with the aid of these lantibiotics and these lactic acid bacteria producing lantibiotics
10/29/1992	WO1992018631A1 Methods and nucleic acid sequences for the expression of the cellulose synthase operon
10/29/1992	WO1992018630A1 Compound comprising a peptide sequence neutralizing the infection by human cytomegalovirus (hcmv) and composition containing such compound
10/29/1992	WO1992018627A1 Glial mitogenic factors, their preparation and use
10/29/1992	WO1992018626A1 WATER-SOLUBLE POLYPEPTIDES HAVING HIGH AFFINITY FOR INTERFERONS α AND $g(b)
10/29/1992	WO1992018624A1 Plasmides for the expression of filamentous haemagglutinin (fha) and hosts therefor
10/29/1992	WO1992018619A1 Heterodimeric receptor libraries using phagemids
10/29/1992	WO1992018610A2 Compositions and methods for endothelial binding
10/29/1992	WO1992018541A1 Dna encoding mammalian phosphodiesterases
10/29/1992	WO1992018538A1 A lymphocyte stimulating factor originating from the haemoflagellate trypanosoma
10/29/1992	WO1992018536A2 Method for detecting an localizing tissues having neurokinine 1 receptors
10/29/1992	WO1992018534A1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1992	WO1992018533A1 Cloned gene encoding rat d1b dopamine receptor
10/29/1992	WO1992018532A1 Rna, dna and virus antigen protein of non-a non-b hepatitis virus
10/29/1992	WO1992018531A1 Growth hormone releasing factor analogs
10/29/1992	WO1992018530A1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN
10/29/1992	WO1992018528A1 Branched peptides in assays for antibodies
10/29/1992	WO1992018527A1 Rapamycin assay
10/29/1992	WO1992018526A1 Production of phosphopeptides from casein
10/29/1992	WO1992018160A2 Method for inhibiting adhesion of white blood cells to endothelial cells
10/29/1992	WO1992018152A1 Use of müllerian inhibiting substance for treatment of certain tumors
10/29/1992	WO1992018150A1 Mhc conjugates useful in ameliorating autoimmunity
10/29/1992	WO1992018149A1 Assay systems for neurotrophin activity
10/29/1992	WO1992018145A1 Purification of müllerian inhibiting substance
10/29/1992	WO1992018142A1 Osteoinductive protein mixtures and purification processes
10/29/1992	WO1992018140A1 Activity-dependent neurotrophic factor
10/29/1992	WO1992018139A1 Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques
10/29/1992	WO1992018138A1 Mammalian gap-43 compositions and methods of use
10/29/1992	WO1992018137A1 Method for inducing bone formation using an extract of human osteosarcoma cell line saos-2
10/29/1992	WO1992018128A1 Methods and compositions for treatment of infection by intracellular parasites
10/29/1992	WO1992018113A1 Identification of a new ehrlichia species from a patient suffering from ehrlichiosis
10/29/1992	WO1992016623A3 Receptors for bombesin-like peptides
10/29/1992	WO1992015607A3 Phenyl amidines derivatives useful as platelet aggregation inhibitors

1 ... 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 2730 2731 2732 2733 ... 2916